Dr. Mark Briggs, Programme Director

Mark Briggs is Head of Cell and Gene Therapy for the Welsh Blood Service and Head of Strategy for Research, Development and Innovation for the Velindre Cancer Centre.  Mark is Programme Lead for Advanced Therapies Wales and co-director of the Midland-Wales Advanced Therapy Treatment Centre (ATTC.) Both of which have a focus on equitable adoption and deployment of cell and gene therapies within the NHS. In his latter corporate years, Mark focussed upon the industrialisation of advanced therapies with a view to enabling safe and robust, turn-key production of both genetically and non-genetically modified cellular therapies.

Andrew Owen, Programme Manager

Tasked as the  Advanced Therapies Programme Manager Andrew is ensuring Wales is best placed to adopt emerging advanced therapies, which will transform the way healthcare is delivered. Andrew has over 13 years experience across health and social care and third sector where he has developed into an experienced programme manager. Andrew has a strong passion for service innovation and improvement and understands the benefits these aspects can offer the Advanced Therapies Wales Programme.

Chloe Dobbin, Service Development and Project Manager

Having recently undertaken the role of Advanced Therapies Wales Project Manager Chloe has 6 years experience working within NHS Wales. Beginning her career in NHS Wales Informatic Service (NWIS) Chloe transitioned across to Cwm Taf Morgannwg University Health Board completing a Graduate Management scheme. Having a wealth of knowledge surrounding infrastructure, service redesign and project management, Chloe is an advocate for service change and is eager to adapt these aspects into her role.

Jasmine Williams, Programme and Project Coordinator

Jasmin Williams has worked within NHS Wales for two years and has a keen interest in rare and genetic conditions. Jasmine is a founding member of a panel within Cardiomyopathy UK that provides support and resources for young people who are diagnosed with congenital heart conditions. Due to this, Jasmine has a substantial amount of knowledge on genetic conditions and is able to transfer these skills to fit her role as Programme and Project Co-ordinator.

Advanced Therapies Leads

Debbie Worthing, Advanced Therapies Lead Research Nurse.

Debbie brings to the ATW programme a wealth of experience of working within the NHS and academia clinical research environment. Working with the advanced  therapies programme is an opportunity to contribute to the development and delivery of future health care treatments.

Nimyrah Caesar, Advanced Therapies Communications Lead

Nimyrah is the lead communications resource for the Advanced Therapies Wales programme. She is responsible for developing and delivering the communications strategy across multiple channels to support ATW and its stakeholders.

Sian Millan, Advanced Therapies Business Analyst 

Sian has over 20 plus years experience of working within Swansea Bay University Health Board, and has recently transitioned to NWIS as a Business Analyst supporting the advanced therapies programme. Sian has been tasked with gaining an understanding of business change needs on behalf of the programme in particular the newly CAR-T therapy ATMP.

Get in touch today
F:01443 622 199
Welsh Blood Service, Ely Valley Road, Talbot Green, Pontyclun, CF72 9WB